Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about CRSP
Recent news which mentions CRSP
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
32
33
Next >
Is CRISPR Therapeutics a Good Stock to Buy Following Approval of Its First Drug?
December 11, 2023
Tickers
BLUE
CRSP
VRTX
Tags
VRTX
Recent Press Releases
BLUE
From
Motley Fool
The 3 Best Cathie Wood Stocks to Buy in December
December 10, 2023
Tickers
ARKK
COIN
CRSP
DKNG
Tags
PTON
CRSP
PACB
From
InvestorPlace
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
December 10, 2023
Tickers
CRSP
MRNA
VRTX
Tags
CRSP
Recent Press Releases
VRTX
From
Motley Fool
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 08, 2023
Tickers
BLUE
CRSP
VRTX
Tags
News
Market News
Trading Ideas
From
Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
EDIT
BLUE
CRSP
From
MarketWatch
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
December 08, 2023
Tickers
CRSP
VRTX
Tags
CRSP
VRTX
Recent Press Releases
From
Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
Tickers
ABBV
CRSP
UNH
VRTX
Tags
Stocks to Buy
Market News
NASDAQ:VRTX;NYSE:UNH;NYSE:ABBV;NASDAQ:CRSP
From
InvestorPlace
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
December 07, 2023
Tickers
CRSP
VRTX
Tags
Market News
CRSP
Recent Press Releases
From
Motley Fool
5 Unstoppable Trends to Invest $1,000 in for 2024
December 07, 2023
Tickers
AMT
AMZN
CRSP
CRWD
Tags
GOOG
AMT
GOOGL
From
Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
Tickers
CRBU
CRSP
GILD
PFE
Tags
GILD
Stocks to Buy
CRBU
From
InvestorPlace
Is This News a Setback or a Step Forward for CRISPR Therapeutics?
December 06, 2023
Tickers
CRSP
Tags
Market News
CRSP
Recent Press Releases
From
Motley Fool
Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
December 06, 2023
Tickers
CRSP
Tags
News
Market News
BZI/POD
From
Benzinga
The Latest Analyst Ratings for CRISPR Therapeutics
December 05, 2023
Tickers
CRSP
Tags
Analyst Ratings
Market News
CRSP
From
Benzinga
CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseases
December 05, 2023
Tickers
CRSP
Tags
Biotech
Benzinga
Analyst Ratings
From
Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Invitae
December 05, 2023
Tickers
AAPL
AMZN
CRSP
NVTA
Tags
CRSP
NVTA
VRTX
From
Motley Fool
The Market's Up This Year. Do You Feel Like You Are Winning?
December 04, 2023
Tickers
CDNS
CRSP
DPZ
IOT
Tags
DPZ
CDNS
CRSP
From
Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Tickers
ARKG
BEAM
CRBU
CRSP
Tags
REGN
HOOD
VERV
From
Motley Fool
Where Will Vertex Pharmaceuticals Be in 10 Years?
December 04, 2023
Tickers
CRSP
MRNA
VRTX
Tags
MRNA
Market News
VRTX
From
Motley Fool
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
December 04, 2023
Tickers
CRSP
Tags
Market News
CRSP
Recent Press Releases
From
Motley Fool
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
December 03, 2023
Tickers
AAPL
CRSP
EBAY
PYPL
Tags
CRSP
EBAY
VRTX
From
Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
Tickers
CRSP
LLY
NVO
PFE
Tags
LLY
CRSP
PFE
From
Motley Fool
5 Top Stocks to Buy Before 2024
December 02, 2023
Tickers
CRSP
ISRG
LLY
PFE
Tags
CRSP
VRTX
LLY
From
Motley Fool
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
December 01, 2023
Tickers
CRSP
VRTX
Tags
Market News
CRSP
VRTX
From
Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
December 01, 2023
Tickers
CRSP
DNA
VRTX
Tags
CRSP
Recent Press Releases
VRTX
From
Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
Tickers
ACLX
CRSP
GILD
VRTX
Tags
CRSP
VRTX
ACLX
From
InvestorPlace
Cathie Wood's ARK Innovation ETF Achieves 35% Gain In November, Its Best Month Since Inception
November 29, 2023
Tickers
ARKF
ARKK
BEAM
COIN
Tags
ETFs
TSLA
PATH
From
Benzinga
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
November 29, 2023
Tickers
BA
CAH
COR
CRSP
Tags
CAH
Trading Ideas
News
From
Benzinga
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
Tickers
AMLX
CRSP
JAZZ
VRTX
Tags
Market News
NASDAQ:AMLX,NASDAQ:JAZZ,NASDAQ:VRTX,NASDAQ:CRSP
Stocks to Buy
From
InvestorPlace
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
November 28, 2023
Tickers
CRSP
NTLA
TDOC
Tags
Market News
CRSP
TDOC
From
Motley Fool
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
November 25, 2023
Tickers
AMZN
CRSP
TMDX
VRTX
Tags
TMDX
Market News
AMZN
From
Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.